On November 19, 2015, during the Hi-Tech Fair, Dapeng New District, together with the Municipal Development and Reform Commission and the Municipal Investment Promotion Agency, held the Shenzhen International Bio Valley Investment Promotion Conference with the theme of “New Opportunities for Investment and Development of the Biological and Life Health Industry”. Nearly 200 elite companies and investment institutions from biotechnology, life and health-related industries attended the conference.
As a key intended partner enterprise of Dapeng New District, Beike Biotechnology was invited to participate in this promotion meeting. At the promotion meeting, Dr. Hu Xiang, chairman of Beike Biotechnology, signed an agreement with Dapeng New District to settle in the International Biovalley. A total of 12 companies signed the contract this time and became the first batch of settlers in Shenzhen International Bio Valley. Gao Guohui, deputy secretary-general of the Shenzhen Municipal Government, Wang Jingdong, secretary of the Party Working Committee of Dapeng New District, Yue Xin, deputy director of the Shenzhen Market and Quality Supervision and Administration Commission, Qiu Xuan, member of the party group and deputy director of the Shenzhen Science and Technology Innovation Commission and other leaders witnessed the signing ceremony.
Beike Biotechnology, as a high-tech biotech enterprise in Shenzhen, has received support from the Shenzhen government and is responsible for the construction and operation of the “Shenzhen Comprehensive Cell Bank” and “Shenzhen (Beike) Regional Cell Preparation Center”. The “Shenzhen Comprehensive Cell Bank + Regional Cell Preparation Center” serves as an important support and innovation carrier for the Shenzhen Municipal Government to develop the “innovation chain + industrial chain” of personalized cell therapy. It provides storage and preparation technical services for stem cells, immune cells and other cell resources to the general public and technical teams settled in our city. Dapeng New District attaches great importance to the development of biology and life health industries, taking the lead in seizing Shenzhen’s leading advantages in genomics, biotherapy and other fields, building a biotherapy innovation carrier, strategic layout in biotechnology and industrialization, and in cutting-edge fields such as clinical diagnosis and treatment, regenerative medicine, to create an internationally competitive bio-industrial system, making Shenzhen International Bio Valley an important carrier to represent the country in global science and technology and industrial competition, and to enhance my country’s innovation capabilities and competitive advantages.
201
News link
After the establishment of Dapeng New District, it has focused on the strategic goal of building “three islands and one district” to create Shenzhen International Biovalley, innovating systems and mechanisms, accelerating the construction of scientific research carriers and the transformation of results, and promoting the development of strategic emerging industries, which has initially formed a new situation driven by technological innovation. At present, innovative institutions such as the Shenzhen National Gene Bank, the Shenzhen Institute of Biological Breeding Innovation of the Chinese Academy of Agricultural Sciences, and the Shenzhen Institute of Agricultural Genomics of the Chinese Academy of Agricultural Sciences have been gradually established to support the construction of the Bio Valley. Science and technology R&D incubation platforms such as the Life Science Industrial Park and the Marine Biology Industrial Park are rising. With the settlement of a number of world-class projects such as the team of Professor Rozman, an academician of the National Academy of Sciences, Medicine, and the Chinese Academy of Engineering, and the team of Professor Marshall, a Nobel Prize winner in medicine, the development pattern of Shenzhen’s east and west wings with “Qianhai Cooperation Zone in the west and Dapeng Biological Valley in the east” is accelerating to take shape.
Currently, the construction of the Bioguba Optical Core Startup Zone has been fully launched, 13 infrastructure projects have been started one after another, and the planning and construction of key industrial carriers such as Biohome is also accelerating. As part of the Shenzhen National Independent Innovation Demonstration Zone, the new district is working hard to implement some of the country’s pilot policies in Baguang. In accordance with the requirements of the “Shenzhen National Independent Innovation Demonstration Zone Construction Implementation Plan”, the new district has comprehensively revised the existing “1+7” talent policy, and combined with the actual conditions of the new district, it has increased support for talent introduction, training, incentives, and housing. In order for Shenzhen and Hong Kong to jointly establish the Shenzhen branch of the National Drug Evaluation Center in the Shenzhen International BioValley, the New District, together with the Municipal Foreign Affairs Office, communicated with the Hong Kong SAR government many times and reached a consensus.